Jing Jin
Impact in
- Oncology top 5%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- Drug Transport and Resistance Mechanisms
- Immunology top 5%
- Immune Response and Inflammation
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 54
- Inflammatory Biomarkers in Disease Prognosis 9
- Colorectal Cancer Surgical Treatments 9
- Lung Cancer Research Studies 8
- Cancer Immunotherapy and Biomarkers 7
- Drug Transport and Resistance Mechanisms 6
- Cancer Cells and Metastasis 5
- Co-authors
- Chaofeng Han (3 shared papers)Xuetao Cao (3 shared papers)Nan Li (2 shared papers)Sheng Xu (1 shared paper)Haibo Liu (1 shared paper)Dan Liu (6 shared papers)Hua Sun (2 shared papers)Geng-Tao Liu (2 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (3 papers)Journal of Clinical Oncology (3 papers)PLoS ONE (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Oncogene (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jing Jin
76 papers receiving 1.8k citations
Jing Jin's Hit Papers
Peers
Comparison fields: 5 of 118
- Oncology 675
- Immunology 500
- Cancer Research 238
- Immunology and Allergy 79
- Molecular Biology 555
Countries citing papers authored by Jing Jin
This map shows the geographic impact of Jing Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Jin more than expected).
Fields of papers citing papers by Jing Jin
This network shows the impact of papers produced by Jing Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Jin. The network helps show where Jing Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Jing Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 362 | |
| 2 | Rare-Earth-Modified NiS2 Improves OH Coverage for an Industrial Alkaline Water Electrolyzer Hit paper breakdown → | 2024 | 91 |
| 3 | 2008 | 74 | |
| 4 | 2020 | 69 | |
| 5 | 2004 | 67 | |
| 6 | 2018 | 64 | |
| 7 | 2020 | 63 | |
| 8 | 2012 | 56 | |
| 9 | 2017 | 53 | |
| 10 | 2016 | 49 | |
| 11 | 2018 | 41 | |
| 12 | 2019 | 41 | |
| 13 | 2016 | 41 | |
| 14 | 2017 | 40 | |
| 15 | 2018 | 40 | |
| 16 | 2018 | 38 | |
| 17 | 2015 | 37 | |
| 18 | 2006 | 31 | |
| 19 | 2017 | 31 | |
| 20 | 2014 | 31 |
About Jing Jin
Jing Jin is a scholar working on Oncology, Molecular Biology, Surgery, Immunology and Pulmonary and Respiratory Medicine, having authored 79 papers that have together received 1.8k indexed citations. Recurring topics across this work include Colorectal and Anal Carcinomas (10 papers), Inflammatory Biomarkers in Disease Prognosis (9 papers), Colorectal Cancer Surgical Treatments (9 papers), Lung Cancer Research Studies (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Drug Transport and Resistance Mechanisms (6 papers), interferon and immune responses (6 papers) and Cancer Cells and Metastasis (5 papers). The work is most often cited by research in Oncology (675 citations), Immunology (500 citations), Cancer Research (238 citations), Immunology and Allergy (79 citations) and Molecular Biology (555 citations). Jing Jin has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Chaofeng Han, Xuetao Cao, Nan Li, Sheng Xu, Haibo Liu, Dan Liu, Hua Sun, Geng-Tao Liu, Weimin Li and Lan Yang. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, PLoS ONE, Cancer Chemotherapy and Pharmacology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.